Junge Zhang
Director/Board Member en OCUGEN, INC. .
Fortuna: 2 M $ al 31/03/2024
Perfil
Junge Zhang is the founder of Biopeptek Pharmaceuticals LLC, where he holds the title of President & Chief Executive Officer starting in 2010.
He is also the founder of Mainline Scientific LLC and Mainline Biosciences, Inc. Currently, he holds the position of Independent Director at Ocugen, Inc. since 2019 and Director at Ocugen OpCo, Inc. since 2015.
He previously held the position of Director at Ocugen, Inc. Dr. Zhang holds a doctorate degree from Drexel University, an undergraduate degree from Wuhan University of Technology, and a graduate degree from the University of Louisiana System.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
OCUGEN INC
0.45% | 14/06/2023 | 1 165 182 ( 0.45% ) | 2 M $ | 31/03/2024 |
Cargos activos de Junge Zhang
| Empresas | Cargo | Inicio |
|---|---|---|
| OCUGEN, INC. | Director/Board Member | 01/09/2019 |
| Ocugen OpCo, Inc. | Director/Board Member | 01/05/2015 |
| Biopeptek Pharmaceuticals LLC | Chief Executive Officer | 01/10/2010 |
Mainline Biosciences, Inc.
 Mainline Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Mainline Biosciences, Inc. manufactures pharmaceutical products. The private company is based in Malvern. The American company was founded by Junge Zhang. Junge Zhang has been the CEO since incorporation. | Chief Executive Officer | - |
Antiguos cargos conocidos de Junge Zhang.
| Empresas | Cargo | Fin |
|---|---|---|
| Mainline Scientific LLC | Founder | - |
Ocugen, Inc. /Old/
 Ocugen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ocugen, Inc. operates as a clinical stage biopharmaceutical firm. It discovers, develops, and commercializes therapies for rare and underserved eye diseases. The firm offers a robust and diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA. | Director/Board Member | - |
Formación de Junge Zhang.
| Drexel University | Doctorate Degree |
| Wuhan University of Technology | Undergraduate Degree |
| University of Louisiana System | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| OCUGEN, INC. | Health Technology |
| Empresas privadas | 5 |
|---|---|
Ocugen, Inc. /Old/
Ocugen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ocugen, Inc. operates as a clinical stage biopharmaceutical firm. It discovers, develops, and commercializes therapies for rare and underserved eye diseases. The firm offers a robust and diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA. | Health Technology |
| Ocugen OpCo, Inc. | |
| Biopeptek Pharmaceuticals LLC | |
Mainline Biosciences, Inc.
Mainline Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Mainline Biosciences, Inc. manufactures pharmaceutical products. The private company is based in Malvern. The American company was founded by Junge Zhang. Junge Zhang has been the CEO since incorporation. | Health Technology |
| Mainline Scientific LLC |
- Bolsa de valores
- Insiders
- Junge Zhang
